{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:07:18Z","timestamp":1790438838794,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001552","name":"Cancer Research Trust New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001509","name":"Royal Society of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001513","name":"Cancer Society of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1093017"],"award-info":[{"award-number":["1093017"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["18-05"],"award-info":[{"award-number":["18-05"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jid.2020.02.042","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T11:21:47Z","timestamp":1588159307000},"page":"2442-2454.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-3953","authenticated-orcid":false,"given":"Jessamy","family":"Tiffen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2651-9671","authenticated-orcid":false,"given":"Stuart J.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-5727","authenticated-orcid":false,"given":"Fabian","family":"Filipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-3297","authenticated-orcid":false,"given":"Dilini","family":"Gunatilake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5518-6605","authenticated-orcid":false,"given":"Abdullah Al","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5833-6605","authenticated-orcid":false,"given":"Carleen","family":"Cullinane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8884-6355","authenticated-orcid":false,"given":"Ken","family":"Dutton-Register","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1448-3923","authenticated-orcid":false,"given":"Lauren","family":"Aoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4760-1033","authenticated-orcid":false,"given":"Nick","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-2248","authenticated-orcid":false,"given":"Aniruddha","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-5896","authenticated-orcid":false,"given":"Euan J.","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6824-8761","authenticated-orcid":false,"given":"Michael R.","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-737X","authenticated-orcid":false,"given":"Peter","family":"Hersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.02.042_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2017.04.030","article-title":"The role of the NORE1A tumor suppressor in oncogene-induced senescence","volume":"400","author":"Barnoud","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2020.02.042_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.02.042_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1101\/gr.114843.110","article-title":"Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis","volume":"21","author":"Bogdanovic","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.jid.2020.02.042_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1101\/gr.133728.111","article-title":"Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk","volume":"22","author":"Brinkman","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jid.2020.02.042_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jid.2020.02.042_bib7","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/nar\/gks150","article-title":"Comparison of alignment software for genome-wide bisulphite sequence data","volume":"40","author":"Chatterjee","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2020.02.042_bib8","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood-2010-10-315457","article-title":"Impact of \u03b22 integrin deficiency on mouse natural killer cell development and function","volume":"117","author":"Crozat","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2020.02.042_bib9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.celrep.2015.07.053","article-title":"PRC2 is required to maintain expression of the maternal Gtl2-Rian-Mirg locus by preventing de novo DNA methylation in mouse embryonic stem cells","volume":"12","author":"Das","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2020.02.042_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gdata.2015.07.020","article-title":"Genome-wide epigenetic cross-talk between DNA methylation and H3K27me3 in zebrafish embryos","volume":"6","author":"de la Calle Mustienes","year":"2015","journal-title":"Genomics Data"},{"key":"10.1016\/j.jid.2020.02.042_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2020.02.042_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/gcc.21932","article-title":"Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene","volume":"51","author":"Dutton-Regester","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2020.02.042_bib13","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.02.042_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ebiom.2017.01.013","article-title":"NFIB mediates BRN2 driven melanoma cell migration and invasion through regulation of EZH2 and MITF","volume":"16","author":"Fane","year":"2017","journal-title":"EBiomedicine"},{"key":"10.1016\/j.jid.2020.02.042_bib15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/tcr.201800091","article-title":"Six years (2012\u20132018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds","volume":"18","author":"Fioravanti","year":"2018","journal-title":"Chem Rec"},{"key":"10.1016\/j.jid.2020.02.042_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.02.042_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.02.042_bib18","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.celrep.2018.03.002","article-title":"Regulation of cellular senescence by polycomb chromatin modifiers through distinct DNA damage- and histone methylation-dependent pathways","volume":"22","author":"Ito","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2020.02.042_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni1111","article-title":"Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking","volume":"5","author":"Katagiri","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2020.02.042_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2020.02.042_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng.159","article-title":"Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation","volume":"40","author":"Kondo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2020.02.042_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","article-title":"Bismark: a flexible aligner and methylation caller for bisulfite-Seq applications","volume":"27","author":"Krueger","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2020.02.042_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature23881","article-title":"Polycomb-like proteins link the PRC2 complex to CpG islands","volume":"549","author":"Li","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.02.042_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/1871520617666170327120747","article-title":"The emerging roles of RASSF5 in human malignancy","volume":"18","author":"Li","year":"2018","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.jid.2020.02.042_bib26","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.02.042_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2017.74.1025","article-title":"Long-term\u00a0outcomes in patients with BRAF V600-mutant metastatic melanoma who\u00a0received dabrafenib combined with trametinib","volume":"36","author":"Long","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2020.02.042_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/jid.2012.283","article-title":"BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma","volume":"133","author":"Mann","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.02.042_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.02.042_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.02.042_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","article-title":"Immunotherapy resistance by inflammation-induced dedifferentiation","volume":"8","author":"Mehta","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.02.042_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2017.10.006","article-title":"Epigenetics of malignant melanoma","volume":"51","author":"Moran","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jid.2020.02.042_bib37","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1038\/sj.onc.1207563","article-title":"Microarray expression profiling in melanoma reveals a BRAF mutation signature","volume":"23","author":"Pavey","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.02.042_bib38","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41388-019-0729-2","article-title":"An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells","volume":"38","author":"Perotti","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.02.042_bib39","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.7150\/thno.19884","article-title":"c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in tumorigenesis","volume":"7","author":"Qu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jid.2020.02.042_bib41","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nprot.2007.202","article-title":"Extraction, purification and analysis of histones","volume":"2","author":"Shechter","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jid.2020.02.042_bib42","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/bioinformatics\/btu126","article-title":"DMAP: differential methylation analysis package for RRBS and WGBS data","volume":"30","author":"Stockwell","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2020.02.042_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/aps.2013.161","article-title":"EZH2: biology, disease, and structure-based drug discovery","volume":"35","author":"Tan","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jid.2020.02.042_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neo.2016.01.003","article-title":"Somatic copy number amplification and hyperactivating somatic mutations of EZH2 correlate with DNA methylation and drive epigenetic silencing of genes involved in tumor suppression and immune responses in melanoma","volume":"18","author":"Tiffen","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.jid.2020.02.042_bib45","doi-asserted-by":"crossref","first-page":"27023","DOI":"10.18632\/oncotarget.4809","article-title":"Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes","volume":"6","author":"Tiffen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.02.042_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2011.10.004","article-title":"Hematologically important mutations: leukocyte adhesion deficiency (first update)","volume":"48","author":"van de Vijver","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jid.2020.02.042_bib49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vir\u00e9","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.02.042_bib50","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.02.042_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/CCO.0000000000000390","article-title":"Targeting EZH2 in cancer therapy","volume":"29","author":"Yamagishi","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jid.2020.02.042_bib53","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The histone methyltransferase Ezh2 controls mechanisms of adaptive resistance to tumor immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2020.02.042_bib54","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/ncomms7051","article-title":"The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors","volume":"6","author":"Zingg","year":"2015","journal-title":"Nat Commun"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20313907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20313907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:45:03Z","timestamp":1762206303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20313907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0022202X20313907"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.02.042","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}